Acute Pancreatitis Associated With Cytarabine During the Treatment of Pediatric Acute Myeloid Leukemia

被引：3
|
作者：
Murshed, Farhan [1 ]
Wong, Victor [3 ]
Koning, Jeffrey L. [2 ]
Kuo, Dennis J. [3 ]
机构：
[1] Univ Calif San Diego, Sch Med, Dept Pediat, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Sch Med, Dept Radiol, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Sch Med, Div Pediat Hematol Oncol, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2020年 / 42卷 / 01期
关键词：
chemotherapy; pancreatitis; leukemia; pharmacology;
D O I：
10.1097/MPH.0000000000001611
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Pancreatitis is a common complication of many pediatric oncology drugs - most commonly asparaginase, followed by pentamidine, mercaptopurine, corticosteroids, and trimethoprim-sulfamethoxazole. Cytarabine-associated pancreatitis is not often mentioned in the pediatric oncology literature. We report the case of a 10-year-old female with acute myeloid leukemia who developed cytarabine-associated pancreatitis.
引用
收藏
页码：63 / 64
页数：2
相关论文
共 50 条
  • [31] Azacitidine Treatment for Pediatric Patients with Acute Myeloid Leukemia
    Kawakami, Ryota
    Isobe, Kiyotaka
    Noguchi, Jun
    Sugawa, Masahiro
    Yanagi, Masato
    Itabashi, Toshikazu
    Mori, Makiko
    Arakawa, Yuki
    Ko, Katsuyoshi
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S68 - S69
  • [32] Epigenetic Therapy for Treatment Pediatric Acute Myeloid Leukemia
    Nemirovchenko, V.
    Popa, A.
    Mentkevich, G.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S201 - S201
  • [33] EPIGENETIC THERAPY FOR TREATMENT PEDIATRIC ACUTE MYELOID LEUKEMIA
    Nemirovchenko, V. S.
    Popa, A. V.
    Mentkevich, G. L.
    [J]. LEUKEMIA RESEARCH, 2014, 38 : S25 - S25
  • [34] Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
    Blanco, JG
    Dervieux, T
    Edick, MJ
    Mehta, PK
    Rubnitz, JE
    Shurtleff, S
    Raimondi, SC
    Behm, FG
    Pui, CH
    Relling, MV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10338 - 10343
  • [35] Treatment of Acute Myeloid Leukemia During Pregnancy
    Chang, Abraham
    Patel, Samit
    [J]. ANNALS OF PHARMACOTHERAPY, 2015, 49 (01) : 48 - 68
  • [36] Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine
    Wiedower, Eric
    Jamy, Omer
    Martin, Michael G.
    [J]. ANTICANCER RESEARCH, 2015, 35 (11) : 6287 - 6290
  • [37] Cross resistance to cytarabine in childhood acute myeloid leukemia
    Hubeek, I
    Peters, GJ
    Broekhuizen, AJF
    Zwaan, CM
    Van Wering, ER
    Creutzig, U
    Kaspers, GJL
    [J]. LEUKEMIA, 2003, 17 (03) : 680 - 680
  • [38] Modulation of cytarabine resistance in childhood acute myeloid leukemia
    Hubeek, I
    Peters, GJ
    Broekhuizen, AJF
    Zwaan, CM
    Creutzig, U
    Kaspers, GJL
    [J]. LEUKEMIA, 2003, 17 (03) : 681 - 681
  • [39] Toward Personalization of Cytarabine Dosing in Acute Myeloid Leukemia
    Jordheim, Lars Petter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (07) : 784 - 786
  • [40] Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia
    Hans Minderman
    Kieran L. O’Loughlin
    Patrick F. Smith
    Lakshmi Pendyala
    William R. Greco
    Kimberly G. Sweeney
    Laurie A. Ford
    Meir Wetzler
    Maria R. Baer
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 57 : 73 - 83
12345